Today: 16 July 2026
Micron Technology rises as analysts look past Nvidia Vera Rubin HBM4 setback

Micron Technology rises as analysts look past Nvidia Vera Rubin HBM4 setback

NEW YORK, March 9, 2026, 15:00 EDT

Micron Technology shares gained roughly 2.3% Monday, with Citi and Susquehanna lifting their price targets ahead of the chipmaker’s results set for March 18. Korean media over the weekend reported Nvidia’s Vera Rubin AI system will use HBM4 chips from Samsung Electronics and SK Hynix, skipping Micron. The stock was changing hands at $378.78 during the afternoon session.

The debate takes on fresh significance with Micron’s fiscal Q2 earnings coming up March 18. Investors are sizing up just how much of the next AI memory cycle Micron can grab. HBM—high-bandwidth memory—refers to stacked DRAM paired with AI accelerators, and right now, Micron stands as one of only three big suppliers worldwide.

Samsung and SK Hynix have landed spots as suppliers for Nvidia’s Vera Rubin platform, according to TrendForce, which cited Hankyung. Micron, meanwhile, is set to supply HBM4 for Rubin CPX—the middle-range chips tuned for inference workloads, not model training. As for allocation and pricing, nothing appears locked in. Nvidia is reportedly pushing for memory speeds north of 10 gigabits per second—faster than the current JEDEC HBM4 spec.

Bullish sentiment held up on Wall Street. Citi bumped its Micron price target to $430, while Susquehanna went higher at $525, Barron’s noted. Citi expects DRAM—the key memory in servers and PCs—to jump 171% in 2026 versus 2025, driven by robust data-center demand.

Richard Windsor, independent analyst at Radio Free Mobile, said he suspects Micron “will be brought on board later in the year” as shipments ramp up. He also noted Micron might dodge a revenue impact, since available industry capacity is mostly spoken for through 2026. Barron’s

Micron’s messaging hasn’t budged. Back in December, the company announced it had locked in both price and volume deals for all of its 2026 HBM production, covering HBM4 as well. Then in February, CFO Mark Murphy told investors Micron began shipping HBM4 to customers a quarter ahead of schedule. He said he was “highly confident” about the product’s performance, quality, and reliability. Micron Technology

Competition hasn’t let up. Samsung announced last month it started shipping HBM4 to clients. SK Hynix, meanwhile, wrapped up internal certification and already has a production system in place. It’s a sharp escalation in the race with Micron.

But there’s a risk here: if Micron really is left out of the first Vera Rubin launch—still not confirmed—that absence could drag on well past what bulls are hoping for. Should Samsung and SK Hynix keep their grip on the top-tier Vera Rubin allocations, Micron may have to settle for less lucrative programs right as its own output ramps up. On top of that, Micron’s filings caution that softer HBM demand could push suppliers to swing production back toward standard DRAM, which might squeeze prices.

The backdrop hasn’t loosened up yet. Back in January, Reuters flagged TrendForce’s call for conventional DRAM contract prices to surge 90% to 95% in Q1—a sharp move that underscores how Micron, like Samsung and SK Hynix, keeps riding the AI-driven demand wave.

Susquehanna analyst Mehdi Hosseini remains upbeat about the near-term cycle, though he cautions that “earnings will peak by mid-2027” before the supply-demand equation levels out. All eyes now turn to Micron’s March 18 report—the next gauge of whether the present shortage is powerful enough to override renewed questions about Micron’s seat in Nvidia’s next AI expansion. Barron’s

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • AtaiBeckley (NASDAQ: ATAI) Soars 31% After Lilly $3.8B Buyout Bid
    July 16, 2026, 10:45 AM EDT. Shares of AtaiBeckley shot up 31% to $7.04 after Eli Lilly launched a $6.75-a-share cash bid, putting the deal value at up to $3.8 billion. Traders pushed the price $0.29 above the offer, betting on the $2.50 per share CVR tied to drug pipeline goals. About 80% of the CVR hinges on VLS-01, now in Phase 2b as a psychedelic treatment, with another 20% tied to BPL-003, which has FDA breakthrough status. The sale is expected to close in Q3, if it clears shareholder and regulatory hurdles. The market is treating most of the current price as cash and leaving some room for the CVR milestones, which still need regulatory and DEA signoffs.
Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Previous Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets
Next Story

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets

Go toTop